Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer a clinical trial
Melanie Royce Roberto Hegg
Jama oncology v. 4, n. 7, p. 977-984, 2018
Chicago 2018
Localização:
FM - Fac. Medicina
(OPI 28171 2018 )(Acessar)